Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
ID: 24-007309Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/3b5ac0426f2b468bb40275e2af7363db/view
Timeline
    Description

    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits

    The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.

    Point(s) of Contact
    Damien Goines
    301568456
    damien.goines@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Currently viewing
    Solicitation
    Similar Opportunities
    ILLUMINA, INC NEXTSEQ 2000 SEQUENCER REAGENT KIT.
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health (NIH), intends to procure the Illumina, Inc NextSeq 2000 Sequencer Reagent Kit on a sole source basis. This procurement is essential for the Center for Cellular Engineering (CCE) to continue its ongoing studies involving bulk RNA-seq, TCR-seq, and single-cell DNA-seq, utilizing specific reagents that are only available from Illumina, Inc. The reagents are critical for maintaining the integrity and efficacy of clinical trials, and switching vendors would necessitate costly requalification processes that could delay patient treatments. Interested parties capable of providing similar products must submit a capability statement by May 23, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov for consideration.
    GEM-X Universal 5' Gene Expression v3, 16 Samples
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of GEM-X Universal 5' Gene Expression v3 reagents, essential for ongoing clinical trials. This acquisition involves the purchase of specific 10X Genomics reagents necessary for isolating PBMCs and processing plasmablasts for single-cell sequencing, which are critical for the continuity of research efforts related to antigen-specific B-cell responses. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 16, 2025, at 10:00 AM EST, and can direct inquiries to Rita Davis at rita.davis@nih.gov or Tonia Alexander at TALEXANDER@NIAID.NIH.GOV.
    10X GENOMICS GEM-X 5’GENE EXPRESSION REAGENTS
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of 10X Genomics GEM-X 5’ Gene Expression Reagents. This acquisition aims to support ongoing clinical trials focused on understanding the pathogenesis of B and T cells in individuals living with HIV, which could lead to significant advancements in HIV treatment and potential cures. The required reagents are critical for analyzing transcriptional activities in lymphocyte subsets, and failure to procure these items may jeopardize the data collection and analysis of taxpayer-funded research. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 22, 2025, at 10:00 AM EST, and can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at TALEXANDER@NIAID.NIH.GOV for further information.
    10X GENOMICS XENIUM PRIME REAGENTS
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and its National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of 10X Genomics Xenium Prime Reagents, which are critical for ongoing research in spatial transcriptomics related to multiple sclerosis. The acquisition includes specific brand name supplies such as the Xenium Prime 5K Human Pan Tissue and Pathways Assay Kit and related custom gene panels, necessary for evaluating drug effects on induced pluripotent stem cell-derived cerebral organoids and human brain tissue. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 23, 2025, at 10:00 AM EST, and can contact Rita Davis or Tonia Alexander for further information regarding the solicitation RFQ-NIAID-25-2261175.
    10X GENOMICS XENIUM PRIME 5K REAGENTS (AMBIS 2261543)
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of 10X Genomics Xenium Prime 5K reagents under solicitation number RFQ-NIAID-25-2261543. This acquisition is aimed at supporting ongoing research projects focused on understanding immune function and autoimmune diseases, particularly through the use of specialized reagents for sequencing and analyzing patient samples. The selected contractor will provide specific products, including a custom gene panel and assay kits, with delivery expected as soon as possible after award. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 22, 2025, at 10:00 AM EST, and can contact Rita Davis or Tonia Alexander for further information.
    10X GENOMICS VISIUM & DUAL INDEX REAGENTS
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking quotes for the procurement of 10X Genomics Visium Prime reagents, which are critical for ongoing research related to human and animal healthcare. This acquisition includes specific brand name supplies necessary for projects focused on oral microbial and immunological characterization, as well as immune responses in chronic inflammatory diseases. The urgency of this procurement is emphasized, as timely delivery is essential for the continuation of research experiments that began prior to January 20, 2025. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 21, 2025, at 10:00 AM EST, and can contact Rita Davis or Tonia Alexander for further information.
    10X GENOMICS VISIUM HD & DUAL INDEX REAGENTS
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of 10X Genomics Visium HD and Dual Index reagents to support ongoing clinical trials. This acquisition is critical for processing sensitive samples related to tick-borne diseases, which are essential for ensuring human safety and biosecurity. The procurement is being conducted under Simplified Acquisition Procedures, with a firm fixed price purchase order expected to be awarded based on technical capability, price, and delivery. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 22, 2025, at 10:00 AM EST. For further inquiries, vendors can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at TALEXANDER@NIAID.NIH.GOV.
    ONE YEAR SERVICE AGREEMENT FOR TWO (2) BD BIOSCIENCES SYMPHONY S6 AND FACSTATION EQUIPMENT, SN R66293700028 and SN R66293700027
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through its National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a one-year service agreement for two BD Biosciences Symphony S6 and FACSTATION equipment. This procurement aims to secure maintenance services for critical laboratory flow cytometers and lasers used in HIV and SIV research, which are essential for analyzing immune responses in experimental samples. The service agreement will ensure the operational reliability of the equipment, including preventive maintenance, unlimited service visits, and priority response times, with a performance period from June 1, 2025, to May 31, 2026. Interested vendors must submit their capability statements and relevant documentation by 10:00 AM EST on May 22, 2025, to the designated contacts, Rita Davis and Tonia Alexander, via the NIH electronic submission system.
    Notice of Intent to Sole Source – Bio-Rad Quality Control Material
    Buyer not available
    The National Institutes of Health (NIH) intends to award a sole-source Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Bio-Rad Laboratories Inc. for the procurement of quality control (QC) materials essential for use with Roche COBAS PRO Solutions analyzers. The required QC materials, which include various levels of tumor markers and immunoassays, are critical for verifying the accuracy and reliability of analyzer results, ensuring that the instruments function correctly and produce precise test outcomes. This procurement is conducted under FAR Part 13, allowing for a single-source solicitation due to the unique specifications of the Bio-Rad products, with a performance period from May 28, 2025, to September 30, 2025. Interested parties who believe they can meet these requirements must submit a capability statement to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by May 27, 2024, at 6:30 AM EST.
    Ongoing Interventional Clinical Trial Study Drugs
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for an ongoing interventional clinical trial study involving drugs. The objective of this procurement is to engage qualified entities capable of providing the necessary drugs and biologicals for the clinical trial, which is critical for advancing medical research and treatment options. The performance will take place in Bethesda, Maryland, and is categorized under the NAICS code 339112, focusing on surgical and medical instrument manufacturing. Interested parties can reach out to Lynda Cole at lynda.cole@nih.gov or call 301-402-7220 for further details. The presolicitation notice indicates that additional information is available in the attached document.